Rahavard Tamin Pharmaceutical Company is a producer of vinyl pyrrolidone homopolymers (PVP) and their derivatives in the Middle East, which has been supplying its products since 2004. Production of polyvinylpyrrolidone (PVP) material started in the first trial in the country in 2002.
Currently, because of the quantitative and qualitative upgrading of this material, it covers all pharmaceutical and non-pharmaceutical companies, and it does not require the country to import this substance and has reached the frontier of self-sufficiency.
Also, due to the production of this highly desirable quality material, this company is now a rival of similar foreign products, especially European countries, and effective steps have been taken to export this substance to all parts of the world.
Rahavard Tamin Pharmaceutical Company policy
Rahavard Tamin Pharmaceutical Company as the manufacturer of pharmaceutical products, pharmaceutical raw materials and the first and only producer of polyvinylpyrrolidone and acrylic copolymers in the Middle East in order to maintain and enhance the effectiveness of processes, systems and their functions by deploying an integrated management system based on the standards:
In addition, in order to meet the needs of the parties concerned, in particular the customers of the organization, the following general objectives are considered:
Understanding the needs of customers and obtaining their satisfaction through the production of quality products in accordance with the GMP rules and regulations and the latest pharmaceutical standards.